Subtypes of HLA-B27: Historyand implications in the pathogenesis of ankylosing spondylitis

Advances in Experimental Medicine and Biology

Volumn 649, Issue , 2009, Pages 159-176

  Reveille, John D ^a   Maganti, Rashmi M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA B27 ANTIGEN; TAPASIN; CARRIER PROTEIN; ISOPROTEIN; LIGAND;

AMINO ACID SUBSTITUTION; ANKYLOSING SPONDYLITIS; ANTIBODY COMBINING SITE; ARTICLE; GENE CONVERSION; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEAVY CHAIN; HISTOCOMPATIBILITY GENE; HLA B27 GENE; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; LIGAND BINDING; MEDICAL HISTORY; MOLECULAR EVOLUTION; MOLECULAR MIMICRY; MOLECULAR PATHOLOGY; NONHUMAN; POINT MUTATION; POPULATION DISTRIBUTION; POPULATION MIGRATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; AMINO ACID SEQUENCE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; REVIEW; SEQUENCE ALIGNMENT;

ALLELES; AMINO ACID SEQUENCE; EVOLUTION, MOLECULAR; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; LIGANDS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; SEQUENCE ALIGNMENT; SPONDYLITIS, ANKYLOSING;

EID: 70349580108     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0298-6_12     Document Type: Article

References (116)

1. Weiss EH, Kuon W, Dorner C et al. Organization, sequence and expression of the HLA-B27 gene: a molecular approach to analyze HLA and disease associations. Immunobiology 1985; 170(5): 367-80. (Pubitemid 16171457)
2. Seemann GH, Rein RS, Brown CS et al. Gene conversion-like mechanisms may generate polymorphism in human class I genes. EMBO J 1986; 5(3):547-552.
3. Rojo S, Aparicio P, Choo SY et al. Structural analysis of an HLA-B27 population variant, B27f. Multiple patterns of amino acid changes within a single polypeptide segment generate polymorphism in HLA-B27. J Immunol 1987; 139(3):831-836. (Pubitemid 17107084)
4. Rojo S, Aparicio P, Choo SY et al. Structural analysis of an HLA-B27 population variant, B27f Multiple patterns of amino acid changes with in a single polypeptide segment generate polymorphism in HLA-B27. J Immunol 1987; 139(3):831-836. (Pubitemid 17107084)
5. Rojo S, Aparicio P, Hansen JA et al. Structural analysis of an HLA-B27 functional variant, B27d, detected in American blacks. J Immunol 1987; 139(10):3396-3401. (Pubitemid 18021993)
6. Vega MA, Wallace L, Rojo S et al. Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak Idefined by cytolytic T-lymphocytes. J Immunol 1985; 135(5):3323-3332. (Pubitemid 16250596)
7. Vega MA, Bragado R, Ivanyi P et al. Molecular analysis ofa functional subtype of HLA-B27. A possible evolutionary pathway for HLA-B27 polymorphism. J Immunol 1986; 137(11):3557-3565. (Pubitemid 17193316)
8. Choo SY, Fan LA, Hansen JA. A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the alpha I domain. J Immunol 1991; 147(1):174-180.
9. *2708). Tissue Antigens 1994; 44(1):47-51. (Pubitemid 24211819)
10. Del PP, D'Amaco M, Fiorillo MT et al. Identification of a novel HLA-B27 subtype by restriction analysis of a cytotoxic gamma delta T-cell clone. J Immunol 1994; 153(7):3093-3100. (Pubitemid 24292534)
11. *2711) encoding an antigen reacting with both B27- and B40-specific antisera. Tissue Antigens 1997; 49(6):649-652. (Pubitemid 27267888)
12. *2712: a serologic B27-negative antigen associated to Bw6. Tissue Antigens 1998; 51(4 Pt 1):394-397.
13. *2713 . Tissue Antigens 1998; 52(2):187-189. (Pubitemid 28395828)
14. Steiner NK, Jones P, Kosman C et al. Novel HLA-B alleles associated with antigens in the 7C CREG. Tissue Antigens 2001; 57(5):486-488. (Pubitemid 32588558)
15. *27 in molecular diagnostics: impact of new alleles and polymorphism outside exons 2 and 3. Tissue Antigens 2002; 60(1):25-35. (Pubitemid 35177021)
16. Steiner NK, Jones P, Kosman C et al. Novel HLA-B alleles associated with antigens in the 7C CREG. Tissue Antigens 2001; 57(5):486-488. (Pubitemid 32588558)
17. *27 in molecular diagnostics: impact of new alleles and polymorphism outside exons 2 and 3. Tissue Antigens 2002; 60(1 ):25-35. (Pubitemid 35177021)
18. *2714 alleles in potential bone marrow donors. Tissue Antigens 2002 ; 59(5):426-429.
19. *2719) identified in a Lebanese patient affected with ankylosing spondylitis, Tissue Antigens 2001; 58(1):30-33. (Pubitemid 32954996)
20. Kim MA et al. Hum Immunol 61(S1):50-50 2000 (abstract) .
21. Gans CP, Mitton W, Ng J et al. Seven new HLA-B alleles associated with antigens in the B7 CREG . Tissue Antigens 2002; 59(3):229-231. (Pubitemid 34666569)
22. *2723. Tissue Antigens 2002; 60(5):400-403. (Pubitemid 36020797)
23. Steiner NK, Gans C, Baldassarre L et al. Twenty-five novel HLA-B alleles. Tissue Antigens 2003: 62(3):263-266. (Pubitemid 37115093)
24. Steiner NK, Gans C, Baldassarre L et al. Twenty-five novel HLA-B alleles. Tissue Antigens 2003: 62(3):263-266. (Pubitemid 37115093)
25. *4705, from an East African population by high-resolution sequence-based typing. Tissue Antigens 2005: 65(2):187-191. (Pubitemid 40342451)
26. Lazaro AM, Cao K, Masaberg C et al. Twenty-three novel HLA-B alleles identified during intermediate-resolution testing. Tissue Antigens 2006: 68(3):245-248 . (Pubitemid 44341799)
27. *2730 allele found in a Slovene patient affected with IgA nephropathy. Inr J Immunogenet 2006: 33(5):371-373. (Pubitemid 44427137)
28. *2734. Tissue Antigens 2006; 68(6):527-528. (Pubitemid 44924130)
29. *2736 by sequence-based typing. Tissue Antigens 2007: 69(4):365-366. (Pubitemid 46481066)
30. Lopez-Larrea C, Gonzalez-Roces S, Alvarez V. HLA-B27 structure, function and disease association. Curr Opin Rheumatol 1996: 8(4):296-308. (Pubitemid 26299807)
31. Spencer Wells: The Journey of Man: A Genetic Odyssey. Princeton University Press. 2002.
32. Diamond J. Guns germs and steel. The Fates of Human Societies. WW Norton and Company, New York, NY 1999.
33. Seemann GH, Rein RS, Brown CS et al. Gene conversion-like mechanisms may generate polymorphism in human class I genes. EMBO J 1986: 5(3):547-552.
34. Seemann GH, Rein RS, Brown CS et al. Gene conversion-like mechanisms may generate polymorphism in human class I genes. EMBO J 1986: 5(3): 547-552.
35. Rojo S, Aparicio P, Choo SY et al. Structural analysis of an HLA-B27 population variant. B27f. Multiple patterns of amino acid changes within a single polypeptide segment generate polymorphism in HLA-B27. J Immunol 1987: 139(3):831-836. (Pubitemid 17107084)
36. Khan MA, Mathieu A, Sorrentino R et al. The pathogenetic role of HLA-B27 and its subtypes. Autoirnmun Rev 2007; 6(3):183-189. (Pubitemid 46187337)
37. *2708). Tissue Antigens 1994; 44(1): 47-51. (Pubitemid 24211819)
38. Cipriani A, Rivera S, Hassanhi M et al. HLA-B27 subtypes determination in patients with ankylosing spondyliris from Zulia, Venezuela. Hum Immunol 2003: 64(7):745-749. (Pubitemid 36828506)
39. Shankarkumar U. HLA-B27 allele diversity in Indians: impact of ethnic origin and the caste system. BrJ Biomed Sci 2003; 60(4 ):223-226. (Pubitemid 38067838)
40. Oguz FS. Ocal L, Oiler AS ec al. HLA B-27 subtypes in turkish patients with spondyloarthropathy and healthy controls . Dis Markers 2004: 20(6):309-312. (Pubitemid 40385310)
41. Fernandez-Sueiro JL , Alonso C, Blanco FJ et al. Prevalence of HLA-B27 and subtypes of HLA-B27 associated with ankylosing spondylitis in Galicia. Spain. Clin Exp Rheurnarol 2004: 22(4):465-468. (Pubitemid 39089808)
42. *2712: a serologic B27-negative antigen associated to Bw6. Tissue Antigens 1998: 51(4 Pt 1):394-397.
43. Yang G, Deng YJ, Yan CX et al. [Frequencies distribution of human leukocyte antigen-B27 subtypes in healthy Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006: 28(2):240-243. (Pubitemid 43826739)
44. MacLean L. HLA-B27 subtypes: implications for the spondyloarthropathies. Ann Rheum Dis 1992: 51(8):929-931.
45. Alaez C, Gazit E, Ibarrola B et al. Distribution of HLA-B27 subtypes in ankylosing spondylitis in an Israeli population. Arch Med Res 2007: 38(4):452-455 . (Pubitemid 46546495)
46. Yang G, Deng YJ , Yan CX et al. [Frequencies distribution of human leukocyte antigen-B27 subtypes in healthy Chinese] . Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006; 28(2);240-243. (Pubitemid 43826739)
47. Taurog JD. Immunology, genetics and animal models ofthe spondyloarthropathles. Curr Opin Rheumatol 1990: 2(4): 586-591. (Pubitemid 20300415)
48. Ma HJ, Hu FP, Diversity of human leukocyte antigen-B27 alleles in han population of hunan province, southern China. Tissue Antigens 2006; 68(2):163-166.
49. Yang G, Deng YJ, Yan CX et al [Frequencies distribution of human leukocyte antigen-B27 subtypes in healthy Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006; 28(2):240-243. (Pubitemid 43826739)
50. Leffell MS, Fallin MD. Hildebrand WH et al. HLA alleles and haplotypes among the lakota sioux: report of the ASHI minority workshops, part III. Hum Immunol 2004, 65(1):78-89. (Pubitemid 38209938)
51. Steiner NK, Jones P, Kosman C et al. Novel HLA-B alleles associated with antigens in the 7C CREG. Tissue Antigens 2001, 57(5):486-488. (Pubitemid 32588558)
52. Leffell MS, Fallin MD, Hildebrand WH et al. HLA alleles and haplotypes among the lakota sioux: report of the ASHI minority workshops, part III. Hum Immunol 2004; 65(1):78-89. (Pubitemid 38209938)
53. Dhaliwal JS, Too CL. Lisut M et al. HLA-B27 polymorphism in the Malays. Tissue Antigens 2003, 62(4):330-332. (Pubitemid 37204588)
54. Ma HJ, Hu FP. Diversity of human leukocyte antigen-B27 alleles in han popularion of hunan province, southern China. Tissue Antigens 2006, 68(2):163-166.
55. Ma HJ, Hu FP. Diversity of human leukocyte antigen-B27 alleles in han population of hunan province, southern China. Tissue Antigens 2006, 68(2):163-166.
56. Yamaguchi A, Ogawa A. Tsuchiya N et al. HLA-B27 subtypes in Japanese with seronegative spondyloarthropathies and healthy controls. J Rheurnarol 1996; 23(7):1189-1193.
57. Lopez-Larrea C, Sujirachato K, Mehra NK et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995; 45(3):169-176.
58. *2736 by sequence-based typing. Tissue Antigens 2007; 69(4):365-366. (Pubitemid 46481066)
59. Dhaliwal JS, Too CL, Lisut M et al. HLA-B27 polymorphism in the Malays. Tissue Antigens 2003 , 62(4):330-332. (Pubitemid 37204588)
60. *2711) encoding an antigen reacting with both B27- and B40-specific antisera. Tissue Antigens 1997; 49(6):649-652. (Pubitemid 27267888)
61. Yang G, Deng YJ, Yan CX et al [Frequencies distribution of human leukocyte antigen-B27 subtypes in healthy Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006; 28(2):240-243. (Pubitemid 43826739)
62. Ma HJ, Hu FP. Diversity of human leukocyte antigen-B27 alleles in Han population of Hunan province, southern China. Tissue Antigens 2006; 68(2):163-166.
63. Garcia-Fernandez S, Gonzalez S, Mina BA et al. New insights regarding HLA-B27 diversity in the asianpopulation. Tissue Antigens 2001; 58(4):259-262. (Pubitemid 34015430)
64. *2714 alleles in potential bone marrow donors. Tissue Antigens 2002 ; 59(5):426-429.
65. Chhaya SU. HLA-B27 polymorphism in Mumbai, Western India . Tissue Antigens 2005; 66(1):48-50. (Pubitemid 40942713)
66. Lazaro AM. Cao K. Masaberg C et al. Twenty-three novel HLA-B alleles identified during intermediate-resolution testing. Tissue Antigens 2006; 68(3): 245-248. (Pubitemid 44341799)
67. *2736 by sequence-based typing. Tissue Antigens 2007; 69(4): 365-366. (Pubitemid 46481066)
68. Lopez-Larrea C, Gonzalez-Roces S, Alvarez V. HLA-B27 structure, function and disease association. Curr Opin Rheumatol 1996; 8(4):296-308. (Pubitemid 26299807)
69. Alaez C, Gazit E, Ibarrola B et al. Distribution of HLA-B27 subtypes in ankylosing spondylitis in an Israeli population. Arch Med Res 2007 ; 38(4):452-455. (Pubitemid 46546495)
70. *2707. Hum Immunol 2004; 65(12):1451-1454. (Pubitemid 39643225)
71. Lopez-Larrea C, Gonzalez-Roces S, Alvarez V. HLA-B27 structure, function and disease association. Curr Opin Rheumarol 1996; 8(4):296-308. (Pubitemid 26299807)
72. Del PP, D'Amato M, Fiorillo MT et al. Identification of a novel HLA-B27 subtype by restriction analysis of a cytotoxic gamma delta T-cell clone. J Immunol 1994; 153(7): 3093-3100. (Pubitemid 24292534)
73. *2719) identified in a lebanese patient affected with ankylosing spondylitis. Tissue Antigens 2001; 58(1):30-33. (Pubitemid 32954996)
74. *2710) that is critical for T-cell recognition has limited effects on peptide specificity. Tissue Antigens 1998; 51(1):1-9. (Pubitemid 28014540)
75. *2710) that is critical for T-cell recognition has limited effects on peptide specificity. Tissue Antigens 1998 ; 51(1):1-9. (Pubitemid 28014540)
76. Garcia-Fernandez S. Gonzalez S. Mina BA et al. New insights regarding HLA-B27 diversity in the asian population. Tissue Antigens 2001, 58(4):259-262. (Pubitemid 34015430)
77. *2734. Tissue Antigens 2006; 68(6):527-528. (Pubitemid 44924130)
78. Lopez-Larrea C, Gonzalez-Roces S, Alvarez V. HLA-B27 structure, function and disease association. Curr Opin RheumatoI 1996; 8(4); 296-308. (Pubitemid 26299807)
79. Gonzalez-Roces S, Alvarez MV, Gonzalez S et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997; 49(2):116-123. (Pubitemid 27084693)
80. Nasution AR, Mardjuadi A, Kunmartini S et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy, J Rheumatol 1997; 24(6):1111-1114. (Pubitemid 27250118)
81. Gonzalez-Roces S, Alvarez MV, Gonzalez S et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997; 49(2):116-123. (Pubitemid 27084693)
82. *2709 allele in ankylosing spondylitis patients and healthy individuals. Dis Markers 1995; 12(3):215-217.
83. Fiorillo MT, Cauli A, Carcassi C et al. Two distinctive HLA haplotypes harbor the B27 allelesnegatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis. Arthritis Rheum 2003; 48(5):1385-1389. (Pubitemid 36554537)
84. Ramos M, Lopez de Castro JA . HLA-B27 and the pathogenesis of spondyloarrhritis. Tissue Antigens 2002; 60(3):191-205.
85. *2709 subtype in a woman with early ankylosing spondylitis. Arthritis Rheum 2007; 56(8):2805-2807. (Pubitemid 47237303)
86. *1403. Arthritis Rheum 2007; 56(8):2807-2809. (Pubitemid 47237304)
87. *1403 in a West African popularion. Arthritis Rheum 2002; 46(11):2968-2971. (Pubitemid 35315890)
88. D'Amato M, Fiorillo MT, Carcassi C et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis . Eur J Immunol1995; 25(11): 3199-3201.
89. *2706) differ by specific changes at three anchor positions. J Biol Chem 2002 ; 277(19):16744-16749. (Pubitemid 34967695)
90. *2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J Bioi Chem 2002; 277(32):28749-28756.
91. Montserrat V, Marti M, Lopez de Castro JA. Allospecific T-cell eplrope sharing reveals extensive conservation of the antigenic features of pepride ligands among HLA-B27 subtypes differentially associated with spondyloarrhritis.J Immunol 2003; 170(11):5778-5785. (Pubitemid 36617872)
92. Khare SO, Lee S, Bull MJ et al. Peptide binding alphalalpha2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice. Hum Immunol 1999; 60(2):116-126. (Pubitemid 29072095)
93. *1403 in a West African population. Arthritis Rheum 2002; 46(11 ):2968-2971. (Pubitemid 35315890)
94. Srarikov EB, Nilsson L, Hulsmeyer M. A single residue exchange between two HLA-B27 alleles triggers increased peptide flexibility. Eur Biophys J 2004; 33(7):651-655. (Pubitemid 40022297)
95. Fabian H, Huser H, Narzi D et al. HLA-B27 subtypes differentially associated with disease exhibit conformational differences in solution. J Mol Biol 2008; 376(3):798-810.
96. Hulsmeyer M. Fiorillo MT, Bettosini F et al. Dual, HLA-B27 subtype-dependent conformarion of a self-peptide. J Exp Med 2004 ; 199(2):271-281. (Pubitemid 38139247)
97. Winkler K, Winter A, Rueckert C et al. Narural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexes. Biophys J 2007; 93(8):2743-2755. (Pubitemid 47607811)
98. Hillig RC, Hulsmeyer M, Saenger W et al. Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J Bioi Chem 2004; 279(1):652-663. (Pubitemid 38044870)
99. Hulsmeyer M, Welfle K, Pohlmann T et al. Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide. J Mol Bioi 2005; 346(5):1367-1379. (Pubitemid 40248835)
100. Fiorillo MT, Meadows L, D'Amato M et al. Susceptibiliry to ankylosing spondylitis correlates with the C-rerminal residue of peptides presented by various HLA-B27 subtypes. Eur J Immunol 1997; 27(2):368-373 . (Pubitemid 27085239)
101. *2704 and other HLA-B27 subtypes associated with ankylosing spondylitis . Tissue Antigens 1997; 49(3 Pt 1):215-221. (Pubitemid 27122564)
102. Lopez de Castro JA, Alvarez I, Marcilla M et al. HLA-B27: a registry of consriturive peptide ligands. Tissue Antigens 2004 ; 63(5):424-445. (Pubitemid 38648208)
103. *2707 peptide morif: Tyr C-terminal anchor is not shared by all disease-associated subtypes. Immunogenetics 1997; 47(1):103-105. (Pubitemid 28062042)
104. *2704 as much as from HLA-B27 subtypes nor associated to spondyloarthritis. Eur J lmmunol 2006 ; 36(7): 1867-1881. (Pubitemid 44089053)
105. Boyle LH, Goodall JC, Opat SS et al. The recognition of HLA-B27 by human CD4(+) T-lymphocytes. J Immunol 2001; 167(5):2619-2624. (Pubitemid 32768890)
106. Ramos M, Alvarez I, Sesma L et al. Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins. J Biol Chem 2002; 277(40):37573-37581.
107. Fiorillo MT, Ruckert C, Hulsmeyer M et al. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J Biol Chem 2005 ; 280(4):2962-2971. (Pubitemid 40189406)
108. Kollnberger S. Bird L. Sun MY et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002; 46(11):2972-2982. (Pubitemid 35315891)
109. Turner MJ, DeLay ML. Bai S et al. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarrhritis-like disease. Arthritis Rheum 2007; 56(1):215-223. (Pubitemid 46106195)
110. Mear JP, Schreiber KL, Munz C et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol 1999; 163(12):6665-6670.
111. *2705. display similar intracellular trafficking and oligomer formation . Arthritis Rheum 2007; 56(7):2232-2242.
112. Edwards JC, Bowness P, Archer JR. Jekyll and Hyde: the transformation of HLA-B27. Immunol Today 2000; 21(6):256-260. (Pubitemid 30333297)
113. Saleki K, Hartigan N, Lith M et al. Differenti al oxidation of HLA-B2704 and HLA-B2705 in lymphoblasroid and transfected adherent cells. Autioxid Redox Signal 2006; 8(3-4):292-299 . (Pubitemid 43741300)
114. Vazquez MN, Lopez de Castro JA. Similar cell surface expression of beta2 -microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis. Arthritis Rheum 2005; 52(10):3290-3299. (Pubitemid 41447112)
115. *2706. J Immunol 2006; 177(10):7015-7023. (Pubitemid 44715068)
116. Goodall JC, Ellis L, Hill Gaston JS. Spondylarthritis-associated and nonspondylarthritis-associared B27 subtypes differ in their dependence upon tapasin for surface expression and their incorporation into the peptide loading complex. Arthritis Rheum 2006 ; 54(1):138-147. (Pubitemid 43122196)